THERAPEUTIC ROUND
Year : 2011 | Volume
: 56 | Issue : 5 | Page : 515--516
Oral itraconazole for the treatment of severe seborrhoeic dermatitis
Jayasri Das1, Monalisa Majumdar2, Urmita Chakraborty2, Vivek Majumdar1, Gautam Mazumdar1, Jayasree Nath1
1 Department of Dermatology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India
2 Department of Microbiology, Calcutta School of Tropical Medicine, Kolkata, West Bengal, India
Correspondence Address:
Jayasree Nath
Department of Dermatology, Calcutta School of Tropical Medicine, CR Avenue, Kolkata - 700 073, West Bengal
India
Background : Seborrheic dermatitis (SD) is an inflammatory skin disorder in which colonies of Malassezia furfur have been found in affected areas. Aim: The aim of this study was to evaluate the efficacy of itraconazole in the treatment of severe SD. Materials and Methods: Itraconazole was given to 30 patients of SD in a dose of 100 mg twice daily for 1 week followed by 200 mg/day for first 2 days of the following 2 months. The response was noted on day 15, 30, 60, and 90. The clinical response was graded as markedly effective, effective, or ineffective. Results: Clinical improvement (evaluated as markedly effective or effective) was observed in 83.3% cases. Conclusion : The anti-inflammatory activity of oral itraconazole suggests that it should be the first-line therapy in severe SD.
How to cite this article:
Das J, Majumdar M, Chakraborty U, Majumdar V, Mazumdar G, Nath J. Oral itraconazole for the treatment of severe seborrhoeic dermatitis.Indian J Dermatol 2011;56:515-516
|
How to cite this URL:
Das J, Majumdar M, Chakraborty U, Majumdar V, Mazumdar G, Nath J. Oral itraconazole for the treatment of severe seborrhoeic dermatitis. Indian J Dermatol [serial online] 2011 [cited 2023 Dec 1 ];56:515-516
Available from: https://www.e-ijd.org/article.asp?issn=0019-5154;year=2011;volume=56;issue=5;spage=515;epage=516;aulast=Das;type=0 |
|
|
|
